- Whitehawk Therapeutics press release (NASDAQ:WHWK): Q2 GAAP EPS of -$0.76.
- Cash, cash equivalents and short-term investments as of June 30, 2025, were $177.2 million as compared to $47.2 million as of December 31, 2024.
Whitehawk Therapeutics GAAP EPS of -$0.76
.png)
2 hours ago
1
Related
Healthcare Trust 7.125% PFD SER B reports Q2 results
7 minutes ago
0
Hennessy Advisors GAAP EPS of $0.26
14 minutes ago
0
Star Holdings GAAP EPS of -$2.95
15 minutes ago
0
Context Therapeutics reports Q2 results
15 minutes ago
0
Nvidia lead big tech in efficiency with record operating mar...
17 minutes ago
0
Essent Group Q2 2025 Earnings Preview
17 minutes ago
0
Popular
Listen to the sounds of a black hole with these NASA sonific...
2 months ago
75
Palm Springs Bombing: What We Know About Fertility Clinic Ex...
2 months ago
66
Oil futures fall as Saudi Arabia said to seek more big OPEC ...
2 months ago
49
This is the next historical period I want to see in Assassin...
2 months ago
44
UK's unemployment rate rises to 4.6% in April
1 month ago
41
English (US) · © Insaro Search Engines 2025. All rights are reserved